About the journal
Prostate Cancer is an open-access journal published by Wiley in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,100 USD. Declared review time at DOAJ: 13 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 2090-3111 · 2090-312X
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,100 USD
- Articles in DOAJ
- 211
- Declared review time
- 13 weeks
- Declared peer-review model
- peer_review
- Official website
- https://onlinelibrary.wiley.com/journal/4757
Index listings
- DOAJ · 2011-12-28
- Indexing
- DOAJ
- APC
- 1,100 USD
- Declared review time (DOAJ)
- 13 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
211
Most recent article
last month
Average review time (journal-declared via DOAJ)
13weeks
Works in OpenAlex
776
Last recorded publication year
2026
h-index
38
i10-index
141
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-12
- Added to DOAJ
- 2011-12-28
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMCPorticoCLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 92%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101567074
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Urologic and reproductive health conditions
- Urologic and reproductive health conditions
Show all subjects (50)
- Advanced Radiotherapy Techniques
- Advanced Radiotherapy Techniques
- Bladder and Urothelial Cancer Treatments
- Bladder and Urothelial Cancer Treatments
- Hormonal and reproductive studies
- Hormonal and reproductive studies
- Urinary Bladder and Prostate Research
- Urinary Bladder and Prostate Research
- Estrogen and related hormone effects
- Global Cancer Incidence and Screening
- Estrogen and related hormone effects
- Global Cancer Incidence and Screening
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Bone health and treatments
- Molecular Biology Techniques and Applications
- Molecular Biology Techniques and Applications
- Bone health and treatments
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Statistical Methods in Clinical Trials
- Ubiquitin and proteasome pathways
- Radiomics and Machine Learning in Medical Imaging
- Statistical Methods in Clinical Trials
- Ubiquitin and proteasome pathways
- Radiomics and Machine Learning in Medical Imaging
- Colorectal Cancer Screening and Detection
- Epigenetics and DNA Methylation
- Sexual Differentiation and Disorders
- Sexual Differentiation and Disorders
- Epigenetics and DNA Methylation
- Colorectal Cancer Screening and Detection
- Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Cancer Risks and Factors
- Cancer Risks and Factors
Keywords (DOAJ)
- male urogenital diseases
- prostatic neoplasms
- prostate cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ